002826 易明医药
已收盘 08-14 15:00:00
资讯
新帖
简况
易明医药最新公告：拟3500万元至7000万元回购公司股份
证券之星 · 08-14 18:40
易明医药最新公告：拟3500万元至7000万元回购公司股份
易明医药：截至2026年8月10日股东数为17,899户
证券之星 · 08-14 17:00
易明医药：截至2026年8月10日股东数为17,899户
8月12日易明医药发布公告，股东减持65.89万股
证券之星 · 08-12
8月12日易明医药发布公告，股东减持65.89万股
股市必读：8月11日易明医药发生1笔大宗交易 成交金额1078.62万元
证券之星 · 08-12
股市必读：8月11日易明医药发生1笔大宗交易 成交金额1078.62万元
股市必读：易明医药（002826）8月5日董秘有最新回复
证券之星 · 08-06
股市必读：易明医药（002826）8月5日董秘有最新回复
股市必读：易明医药新发布《关于持股5%以上股东股份变动触及1%及减持至5%以下暨披露简式权益变动报告书的提示性公告》
证券之星 · 08-05
股市必读：易明医药新发布《关于持股5%以上股东股份变动触及1%及减持至5%以下暨披露简式权益变动报告书的提示性公告》
8月3日易明医药发布公告，股东减持124.11万股
证券之星 · 08-03
8月3日易明医药发布公告，股东减持124.11万股
7月30日易明医药现1826.9万元大宗交易
证券之星 · 07-30
7月30日易明医药现1826.9万元大宗交易
易明医药(002826)7月20日股东户数1.65万户，较上期减少0.74%
证券之星 · 07-22
易明医药(002826)7月20日股东户数1.65万户，较上期减少0.74%
易明医药：截至2026年7月20日股东数为16,512户
证券之星 · 07-22
易明医药：截至2026年7月20日股东数为16,512户
易明医药：截至2026年7月10日股东数为16,635户
证券之星 · 07-14
易明医药：截至2026年7月10日股东数为16,635户
股市必读：易明医药(002826)股东户数1.5万户，较上期减少1.7%
证券之星 · 07-07
股市必读：易明医药(002826)股东户数1.5万户，较上期减少1.7%
易明医药（002826）发布关于变更投资者热线电话及传真号码的公告，7月6日股价上涨1.1%
证券之星 · 07-06
易明医药（002826）发布关于变更投资者热线电话及传真号码的公告，7月6日股价上涨1.1%
7月2日易明医药（002826）龙虎榜数据：机构净买入1712.06万元（3日）
证券之星 · 07-02
7月2日易明医药（002826）龙虎榜数据：机构净买入1712.06万元（3日）
7月1日易明医药（002826）涨停分析：新品获批、一致性评价驱动
证券之星 · 07-01
7月1日易明医药（002826）涨停分析：新品获批、一致性评价驱动
异动快报：易明医药（002826）7月1日14点16分触及涨停板
证券之星 · 07-01
异动快报：易明医药（002826）7月1日14点16分触及涨停板
易明医药(002826)6月18日股东户数1.53万户，较上期减少2.35%
证券之星 · 06-24
易明医药(002826)6月18日股东户数1.53万户，较上期减少2.35%
易明医药：截至2026年6月18日，本公司股东数为15,300户
证券之星 · 06-24
易明医药：截至2026年6月18日，本公司股东数为15,300户
每周股票复盘：易明医药（002826）股东户数降至1.57万户
证券之星 · 06-21
每周股票复盘：易明医药（002826）股东户数降至1.57万户
易明医药（002826）18万股限售股将于6月18日解禁，占总股本0.09%
证券之星 · 06-18
易明医药（002826）18万股限售股将于6月18日解禁，占总股本0.09%
暂无数据
公司概况
公司名称：
西藏易明西雅医药科技股份有限公司
所属行业：
医药制造业
上市日期：
2016-12-09
主营业务：
西藏易明西雅医药科技股份有限公司的主营业务是药品生产销售及药品市场推广服务。公司的主要产品是化学药、中成药。
发行价格：
6.06
{"stockData":{"symbol":"002826","market":"SZ","secType":"STK","nameCN":"易明医药","latestPrice":17.67,"timestamp":1786691019000,"preClose":17.63,"halted":0,"volume":5497600,"delay":0,"changeRate":0.0023,"floatShares":185000000,"shares":191000000,"eps":0.4901,"marketStatus":"已收盘","change":0.04,"latestTime":"08-14 15:00:00","open":17.71,"high":18.4,"low":17.28,"amount":97252000,"amplitude":0.0635,"askPrice":17.68,"askSize":33,"bidPrice":17.67,"bidSize":39,"shortable":0,"etf":0,"ttmEps":0.4901,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1786930200000},"marketStatusCode":5,"adr":0,"adjPreClose":17.63,"symbolType":"stock","openAndCloseTimeList":[[1786671000000,1786678200000],[1786683600000,1786690800000]],"highLimit":19.39,"lowLimit":15.87,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":190677750,"isCdr":false,"pbRate":4.01,"roa":"--","peRate":36.053867,"roe":"2.38%","epsLYR":0.5,"committee":0.725989,"marketValue":3369000000,"turnoverRate":0.0298,"status":0,"floatMarketCap":3264000000},"requestUrl":"/m/hq/s/002826/tweets","defaultTab":"tweets","newsList":[{"id":"2659143652","title":"易明医药最新公告：拟3500万元至7000万元回购公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2659143652","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659143652?lang=zh_cn&edition=full","pubTime":"2026-08-14 18:40","pubTimestamp":1786704034,"startTime":"0","endTime":"0","summary":"易明医药(002826.SZ)公告称，公司拟使用自有资金以集中竞价方式回购股份，回购资金总额不低于3500万元且不超过7000万元，回购价格不超过25.74元/股。按回购金额上限测算，预计回购股份约272万股，占公司总股本的1.43%；按下限测算，预计回购约136万股，占总股本的0.71%。回购股份将用于股权激励或员工持股计划，实施期限为自董事会审议通过之日起12个月内。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081400033166.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","BK0239","002826","BK0033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659152112","title":"易明医药：截至2026年8月10日股东数为17,899户","url":"https://stock-news.laohu8.com/highlight/detail?id=2659152112","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659152112?lang=zh_cn&edition=full","pubTime":"2026-08-14 17:00","pubTimestamp":1786698048,"startTime":"0","endTime":"0","summary":"证券之星消息，易明医药(002826)08月14日在投资者关系平台上答复投资者关心的问题。投资者提问：您好！请问截至8月0日公司股东人数是多少，谢谢！易明医药回复：尊敬的投资者，您好，根据中登结算深圳分公司最新下发的股东名册，截至2026年8月10，本公司股东数为17,899户，感谢关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081400027924.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","BK0239","BK0056","002826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658903501","title":"8月12日易明医药发布公告，股东减持65.89万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2658903501","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658903501?lang=zh_cn&edition=full","pubTime":"2026-08-12 22:01","pubTimestamp":1786543265,"startTime":"0","endTime":"0","summary":"证券之星消息，8月12日易明医药发布公告《易明医药:关于原持股5%以上股东减持计划实施完成的公告》，其股东周战于2026年8月11日合计减持65.89万股，占公司目前总股本的0.3456%，变动期间该股股价下跌1.57%，截止8月11日收盘报17.51元。股东增减持详情见下表：根据易明医药2026年一季报公布的十大股东详情如下：本文数据来源于易明医药公告，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200039859.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002826","BK0056","BK0033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658591769","title":"股市必读：8月11日易明医药发生1笔大宗交易 成交金额1078.62万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2658591769","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658591769?lang=zh_cn&edition=full","pubTime":"2026-08-12 02:03","pubTimestamp":1786471398,"startTime":"0","endTime":"0","summary":"截至2026年8月11日收盘，易明医药报收于17.51元，下跌1.57%，换手率3.02%，成交量5.59万手，成交额9859.78万元。当日关注点交易信息汇总：8月11日主力资金净流出310.15万元，游资资金净流出801.15万元，散户资金净流入1111.3万元； 交易信息汇总：8月11日发生1笔大宗交易，成交金额1078.62万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200002025.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","BK0239","002826","BK0033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657521140","title":"股市必读：易明医药（002826）8月5日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2657521140","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657521140?lang=zh_cn&edition=full","pubTime":"2026-08-06 01:38","pubTimestamp":1785951494,"startTime":"0","endTime":"0","summary":"截至2026年8月5日收盘，易明医药报收于16.5元，上涨0.3%，换手率2.02%，成交量3.73万手，成交额6147.74万元。董秘最新回复投资者： 请问截止到7月31日w公司股东人数是多少？谢谢董秘： 尊敬的投资者，您好，根据中登结算深圳分公司下发的股东名册，截至2026年7月31日，本公司股东数为16,049户。交易信息汇总资金流向8月5日主力资金净流入520.68万元，占总成交额8.47%；游资资金净流入9.18万元，占总成交额0.15%；散户资金净流出529.86万元，占总成交额8.62%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080600001546.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0033","002826","BK0056"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657656598","title":"股市必读：易明医药新发布《关于持股5%以上股东股份变动触及1%及减持至5%以下暨披露简式权益变动报告书的提示性公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2657656598","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657656598?lang=zh_cn&edition=full","pubTime":"2026-08-05 02:53","pubTimestamp":1785869590,"startTime":"0","endTime":"0","summary":"公司公告汇总关于持股5%以上股东股份变动触及1%及减持至5%以下暨披露简式权益变动报告书的提示性公告西藏易明西雅医药科技股份有限公司于2026年8月4日发布公告，持股5%以上股东周战先生因自身资金需要，于2026年7月30日通过大宗交易方式减持公司股份1,241,100股，占公司总股本的0.651%。本次权益变动后，周战持股比例降至5%以下，不再属于持股5%以上股东，公司控制权未发生变化。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500002373.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","BK0033","BK0239","002826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656371760","title":"8月3日易明医药发布公告，股东减持124.11万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2656371760","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656371760?lang=zh_cn&edition=full","pubTime":"2026-08-03 21:00","pubTimestamp":1785762059,"startTime":"0","endTime":"0","summary":"证券之星消息，8月3日易明医药发布公告《易明医药:西藏易明西雅医药科技股份有限公司简式权益变动报告书(周战)》，其股东周战于2026年7月30日合计减持124.11万股，占公司目前总股本的0.6509%，变动期间该股股价下跌3.0%，截止7月30日收盘报15.51元。股东增减持详情见下表：根据易明医药2026年一季报公布的十大股东详情如下：本文数据来源于易明医药公告，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300034653.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","BK0239","BK0056","002826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655310820","title":"7月30日易明医药现1826.9万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2655310820","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655310820?lang=zh_cn&edition=full","pubTime":"2026-07-30 17:47","pubTimestamp":1785404844,"startTime":"0","endTime":"0","summary":"证券之星消息，7月30日易明医药发生大宗交易，交易数据如下：大宗交易成交价格14.72元，相对当日收盘价折价5.09%，成交124.11万股，成交金额1826.9万元，买方营业部为国泰海通证券股份有限公司广州琶洲大道证券营业部，卖方营业部为广发证券股份有限公司成都东大路证券营业部。近三个月该股共发生1笔大宗交易，合计成交1.24万手，折价成交1笔。截至2026年7月30日收盘，易明医药报收于15.51元，下跌3.0%，换手率1.55%，成交量2.87万手，成交额4503.98万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026073000027915.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002826","BK0239","BK0033","BK0056"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653561767","title":"易明医药(002826)7月20日股东户数1.65万户，较上期减少0.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653561767","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653561767?lang=zh_cn&edition=full","pubTime":"2026-07-22 17:45","pubTimestamp":1784713556,"startTime":"0","endTime":"0","summary":"证券之星消息，近日易明医药披露，截至2026年7月20日公司股东户数为1.65万户，较7月10日减少123.0户，减幅为0.74%。在化学制药行业个股中，易明医药股东户数低于行业平均水平，截至7月20日，化学制药行业平均股东户数为3.58万户。从股价来看，2026年7月10日至2026年7月20日，易明医药区间跌幅为5.39%，在此期间股东户数减少123.0户，减幅为0.74%。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072200036502.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0056","002826","BK0033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653730043","title":"易明医药：截至2026年7月20日股东数为16,512户","url":"https://stock-news.laohu8.com/highlight/detail?id=2653730043","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653730043?lang=zh_cn&edition=full","pubTime":"2026-07-22 16:01","pubTimestamp":1784707263,"startTime":"0","endTime":"0","summary":"证券之星消息，易明医药(002826)07月21日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，请问公司截止2026年07月20日的最新股东人数是多少人？谢谢易明医药回复：尊敬的投资者，您好，根据中登结算深圳分公司下发的股东名册，截至2026年7月20日，本公司股东数为16,512户。感谢关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072200029634.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0056","002826","BK0033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651173237","title":"易明医药：截至2026年7月10日股东数为16,635户","url":"https://stock-news.laohu8.com/highlight/detail?id=2651173237","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651173237?lang=zh_cn&edition=full","pubTime":"2026-07-14 16:15","pubTimestamp":1784016911,"startTime":"0","endTime":"0","summary":"证券之星消息，易明医药(002826)07月14日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘：您好！ 麻烦您告知公司截止7月10日的股东人数，谢谢！易明医药回复：尊敬的投资者，您好，根据中登结算深圳分公司下发的股东名册，截至2026年7月10日，本公司股东数为16,635户。感谢关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400030240.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","BK0056","BK0239","002826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649467524","title":"股市必读：易明医药(002826)股东户数1.5万户，较上期减少1.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2649467524","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649467524?lang=zh_cn&edition=full","pubTime":"2026-07-07 02:08","pubTimestamp":1783361294,"startTime":"0","endTime":"0","summary":"截至2026年7月6日收盘，易明医药报收于18.3元，上涨1.1%，换手率5.85%，成交量10.8万手，成交额1.99亿元。股本股东变化：截至2026年6月30日，股东户数为1.5万户，较6月18日减少260户，减幅1.7%。公司公告汇总：易明医药自即日起启用新的投资者热线电话及传真号码，均变更为028-85323589，原号码停用。股本股东变化股东户数变动截至2026年6月30日公司股东户数为1.5万户，较6月18日减少260.0户，减幅为1.7%；户均持股数量由1.25万股增至1.27万股，户均持股市值为19.06万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070700000977.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","002826","BK0239","BK0033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649020627","title":"易明医药（002826）发布关于变更投资者热线电话及传真号码的公告，7月6日股价上涨1.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2649020627","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649020627?lang=zh_cn&edition=full","pubTime":"2026-07-06 22:42","pubTimestamp":1783348937,"startTime":"0","endTime":"0","summary":"截至2026年7月6日收盘，易明医药报收于18.3元，较前一交易日上涨1.1%，最新总市值为34.89亿元。该股当日开盘17.92元，最高19.0元，最低17.57元，成交额达1.99亿元，换手率为5.85%。近日，西藏易明西雅医药科技股份有限公司发布《关于变更投资者热线电话及传真号码的公告》。公告显示，公司自即日起启用新的投资者热线电话及传真号码，原号码停止使用。公司董事会秘书和证券事务代表联系电话同步变更。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070600037820.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","BK0056","002826","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648505000","title":"7月2日易明医药（002826）龙虎榜数据：机构净买入1712.06万元（3日）","url":"https://stock-news.laohu8.com/highlight/detail?id=2648505000","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648505000?lang=zh_cn&edition=full","pubTime":"2026-07-02 17:41","pubTimestamp":1782985299,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年7月2日公布的交易公开信息显示，易明医药因连续三个交易日内，涨幅偏离值累计达到20%的证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年7月2日收盘，易明医药报收于18.18元，上涨9.98%，已连续涨停2天，换手率3.84%，成交量7.09万手，成交额1.27亿元。从龙虎榜公布的三日买卖数据来看，机构合计净买入1712.06万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070200029789.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","002826","BK0056","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648513597","title":"7月1日易明医药（002826）涨停分析：新品获批、一致性评价驱动","url":"https://stock-news.laohu8.com/highlight/detail?id=2648513597","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648513597?lang=zh_cn&edition=full","pubTime":"2026-07-01 15:37","pubTimestamp":1782891466,"startTime":"0","endTime":"0","summary":"证券之星消息，易明医药7月1日涨停收盘，收盘价16.53元。7月1日易明医药涨停的可能因素有：公司于6月28日公告全资子公司获得盐酸右美托咪定注射液《药品注册证书》，该品种为临床常用镇静药，属国家医保目录品种；同期公司披露蒙脱石散通过仿制药一致性评价，叠加7月起新版医保药品目录执行预期，市场对公司存量产品放量及新获批品种商业化落地关注度提升。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100024711.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","BK0239","002826","BK0033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648590842","title":"异动快报：易明医药（002826）7月1日14点16分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2648590842","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648590842?lang=zh_cn&edition=full","pubTime":"2026-07-01 14:25","pubTimestamp":1782887123,"startTime":"0","endTime":"0","summary":"证券之星7月1日盘中消息，14点16分易明医药（002826）触及涨停板。其所属行业化学制药目前上涨。领涨股为宣泰医药。该股为医药，中药，西藏概念概念热股，当日医药概念上涨4.36%，中药概念上涨4.17%，西藏概念概念上涨3.89%。6月30日的资金流向数据方面，主力资金净流出807.19万元，占总成交额9.82%，游资资金净流入413.5万元，占总成交额5.03%，散户资金净流入393.68万元，占总成交额4.79%。近5日资金流向一览见下表：易明医药主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100023399.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002826","BK0033","BK0056"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645999938","title":"易明医药(002826)6月18日股东户数1.53万户，较上期减少2.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645999938","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645999938?lang=zh_cn&edition=full","pubTime":"2026-06-24 17:38","pubTimestamp":1782293919,"startTime":"0","endTime":"0","summary":"证券之星消息，近日易明医药披露，截至2026年6月18日公司股东户数为1.53万户，较6月10日减少369.0户，减幅为2.35%。在化学制药行业个股中，易明医药股东户数低于行业平均水平，截至6月18日，化学制药行业平均股东户数为3.54万户。从股价来看，2026年6月10日至2026年6月18日，易明医药区间涨幅为10.94%，在此期间股东户数减少369.0户，减幅为2.35%。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062400032517.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002826","BK0239","BK0056","BK0033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645586868","title":"易明医药：截至2026年6月18日，本公司股东数为15,300户","url":"https://stock-news.laohu8.com/highlight/detail?id=2645586868","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645586868?lang=zh_cn&edition=full","pubTime":"2026-06-24 08:48","pubTimestamp":1782262089,"startTime":"0","endTime":"0","summary":"证券之星消息，易明医药(002826)06月23日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截至6月20日公司股东人数是多少？谢谢易明医药回复：尊敬的投资者您好，根据中登结算深圳分公司最新下发的股东名册，截至2026年6月18日，本公司股东数为15,300户。感谢关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062400008178.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","BK0033","002826","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645968090","title":"每周股票复盘：易明医药（002826）股东户数降至1.57万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2645968090","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645968090?lang=zh_cn&edition=full","pubTime":"2026-06-21 02:40","pubTimestamp":1781980821,"startTime":"0","endTime":"0","summary":"公司公告汇总关于2024年限制性股票激励计划预留授予第一个解除限售期解除限售股份上市流通的提示性公告西藏易明西雅医药科技股份有限公司2024年限制性股票激励计划预留授予第一个解除限售期解除限售条件已成就，本次解除限售的激励对象共7人，解除限售的限制性股票数量为18.00万股，占公司总股本的0.0944%。解除限售股份上市流通日期为2026年6月18日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062100000760.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002826","BK0239","BK0056","BK0033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644075720","title":"易明医药（002826）18万股限售股将于6月18日解禁，占总股本0.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2644075720","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2644075720?lang=zh_cn&edition=full","pubTime":"2026-06-18 08:09","pubTimestamp":1781741356,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息整理，易明医药于6月18日将有18.0万股限售股份解禁，为公司股权激励限售股份，占公司总股本0.09%。最近一年内，该股累计解禁172.0万股，占总股本的0.9%。本次解禁后，公司还有594.84万股限售股份，占总股本3.12%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061800006803.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","002826","BK0239","BK0056"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1786833647609,"stockEarnings":[{"period":"1week","weight":-0.0095},{"period":"1month","weight":0.0285},{"period":"3month","weight":-0.0303},{"period":"6month","weight":-0.1211},{"period":"1year","weight":-0.2408},{"period":"ytd","weight":-0.0293}],"compareEarnings":[{"period":"1week","weight":-0.0033},{"period":"1month","weight":-0.0072},{"period":"3month","weight":-0.0503},{"period":"6month","weight":-0.0379},{"period":"1year","weight":0.0711},{"period":"ytd","weight":-0.0105}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"西藏易明西雅医药科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"17899人(较上一季度增加11.53%)","perCapita":"10320股","listingDate":"2016-12-09","address":"西藏自治区拉萨市堆龙德庆区经济技术开发区林琼岗路6号","registeredCapital":"19067万元","survey":" 西藏易明西雅医药科技股份有限公司的主营业务是药品生产销售及药品市场推广服务。公司的主要产品是化学药、中成药。","listedPrice":6.06},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"易明医药(002826)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供易明医药(002826)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"易明医药,002826,易明医药股票,易明医药股票老虎,易明医药股票老虎国际,易明医药行情,易明医药股票行情,易明医药股价,易明医药股市,易明医药股票价格,易明医药股票交易,易明医药股票购买,易明医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"易明医药(002826)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供易明医药(002826)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}